BIOMAT Database Logo BIOMAT Database Logo

Paroxetine and the electroencephalogram. 1987

E M Sedgwick, and J Cilasun, and J G Edwards
Wessex Neurological Centre, Southampton General Hospital, Southampton, SO9 4XY, UK.

Electroencephalograms, recorded before and after 4 weeks' treatment with parox etine or placebo, were assessed blind to patient, treatment and treatment interval. No signifi cant differences were found between the paroxetine and the placebo groups. There were no signs of drowsiness or epileptiform activity in the recordings of patients receiving either drug or placebo. The results are discussed in relation to those of pharmacological studies in animals, psychomotor testing and electroencephalographic studies in humans.

UI MeSH Term Description Entries

Related Publications

E M Sedgwick, and J Cilasun, and J G Edwards
The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure.
January 1989, Acta psychiatrica Scandinavica. Supplementum,
E M Sedgwick, and J Cilasun, and J G Edwards
Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data.
February 1999, The Journal of clinical psychiatry,
E M Sedgwick, and J Cilasun, and J G Edwards
Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.
October 2017, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
E M Sedgwick, and J Cilasun, and J G Edwards
Erratum to: Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.
October 2017, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
E M Sedgwick, and J Cilasun, and J G Edwards
Paroxetine and the FDA.
February 2004, Journal of the American Academy of Child and Adolescent Psychiatry,
E M Sedgwick, and J Cilasun, and J G Edwards
Paroxetine and the FDA.
February 2004, Journal of the American Academy of Child and Adolescent Psychiatry,
E M Sedgwick, and J Cilasun, and J G Edwards
Paroxetine and the FDA.
February 2004, Journal of the American Academy of Child and Adolescent Psychiatry,
E M Sedgwick, and J Cilasun, and J G Edwards
Paroxetine mesylate: comparable to paroxetine hydrochloride?
February 2010, Expert opinion on pharmacotherapy,
E M Sedgwick, and J Cilasun, and J G Edwards
[The electroencephalogram and stereo-electroencephalogram in epileptic and psychotic patients].
May 1987, Casopis lekaru ceskych,
E M Sedgwick, and J Cilasun, and J G Edwards
Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR.
January 2003, Psychopharmacology bulletin,
Copied contents to your clipboard!